drugset / Trial / NCT02961790

Oxybutynin Chloride in Managing Hot Flashes

NCT02961790

RandomizedParallel-groupDouble-blindSupportive care

Summary

This randomized phase III trial studies how well oxybutynin chloride works in managing hot flashes in patients who are not candidates for, or not interested in hormone replacement therapy. Previous studies have shown that oxybutynin is effective in managing hot flashes, however doses used in prior studies have resulted in side effects. This trial is evaluating lower doses of oxybutynin with the goal of determining if they are efficacious with less side effects. ADAM-VTE

Timeline

Start
2016-12-09
Primary completion
2018-04-27
Completion
2018-04-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxybutynin Small molecule Oral